Moving forward with intra-arterial and intravenous stroke treatment.
Kennedy
James
J
Nuffield Department of Clinical Medicine, Oxford Acute Stroke Programme, John Radcliffe Hospital, Oxford, UK.
Buchan
Alastair M
AM
D002986:Clinical Trials as Topic; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D007261:Infusions, Intra-Arterial; D007275:Injections, Intravenous; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator